Analysis – Page 75 – Goldea Capital

Northrop Grumman Breaks Ground on New Facility to Support Strategic Deterrence and Advanced Aerospace Missions in Utah

Written by Customer Service on July 14, 2026. Posted in Public Companies.

As the largest defense contractor in Utah, the company marks a pivotal moment for growth, aerospace innovation and national defense investment ROY, Utah, July 14, 2026 (GLOBE NEWSWIRE) — Northrop Grumman (NYSE: NOC) broke ground on a new building at its expansive Roy Innovation Center (RIC), the central campus tailor-made to develop the U.S. Air Force Sentinel Intercontinental Ballistic Missile (ICBM) program and other critical aerospace and defense missions. Northrop Grumman’s investment to expand the footprint of the Sentinel program will create hundreds of new jobs and supports the accelerated timeline to deliver Sentinel initial capability to the U.S. Air Force by the early 2030s while enabling long-term growth across multiple national security programs. The new addition brings the RIC campus to a total of six state-of-the-art...

Atlas One Capital Corporation Announces Letter of Intent for Qualifying Transaction with Ramsden Metals Inc.

Written by Customer Service on July 14, 2026. Posted in Public Companies.

Toronto, Ontario, July 14, 2026 (GLOBE NEWSWIRE) — Atlas One Capital Corporation (TSXV: ACAP.P) (the “Corporation” or “Atlas One”), a capital pool company listed on the TSX Venture Exchange (“TSXV”), has entered into a binding letter of intent with Ramsden Metals Inc. (“Ramsden Metals”) dated July 12, 2026 (the “Letter of Intent”) in respect of a proposed business combination transaction pursuant to which Atlas One will acquire all of the issued and outstanding securities of Ramsden Metals (the “Proposed Transaction”). It is anticipated that the Proposed Transaction will constitute the qualifying transaction of Atlas One in accordance with Policy 2.4 – Capital Pool Companies of the Corporate Finance Manual (the “CPC Policy”) of the TSXV. The resulting company following the completion of the Proposed Transaction is referred...

Churchill Capital Corp IX Announces its Intention to Liquidate

Written by Customer Service on July 14, 2026. Posted in Public Companies.

New York, New York, July 14, 2026 (GLOBE NEWSWIRE) — Churchill Capital Corp IX (NASDAQ: CCIX) (the “Company”), a publicly traded special purpose acquisition company, today announced that its board of directors (the “Board”) has determined to redeem all of its outstanding Class A ordinary shares, par value $0.0001 per share (“Class A Ordinary Shares”), sold in its initial public offering (the “public shares”) because the Company is unable to complete an initial business combination by the deadline under its Amended and Restated Memorandum and Articles of Association. Accordingly, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than ten business days thereafter, subject to lawfully available funds therefor, redeem the public shares, at a per-share...

Beeline to Host Stakeholder Update Call on Q2 2026 Financial Results

Written by Customer Service on July 14, 2026. Posted in Earnings Releases And Operating Results.

PROVIDENCE, R.I., July 14, 2026 (GLOBE NEWSWIRE) — via IBN – Beeline Holdings, Inc. (NASDAQ: BLNE), the fast-growing digital mortgage platform redefining the path to homeownership, today announced it will host a stakeholder update call on the results of the second quarter of 2026 on Thursday, Aug. 13, 2026, at 5 p.m. ET. The call will be hosted by Nick Liuzza, Chief Executive Officer, and Chris Moe, Chief Financial Officer, who will review the company’s performance and provide updates on ongoing initiatives. Call Details:Listen-only webcast: https://event.choruscall.com/mediaframe/webcast.html?webcastid=vxAcpqFkToll-Free Dial-In (U.S.): 877-317-6789 International Dial-In: 412-317-6789About Beeline Beeline Holdings, Inc. is a trailblazing mortgage fintech transforming the way people access property financing. Through...

Glucotrack and Lōkahi Therapeutics Complete Strategic Business Combination, Establishing Lōkahi-Controlled Public Platform

Written by Customer Service on July 14, 2026. Posted in Mergers And Acquisitions.

Transaction positions the combined company to execute a capital-efficient, repeatable strategy leveraging public market access and Lōkahi Therapeutics ai²-driven asset sourcing, development, and advancement platform RUTHERFORD, N.J. and LA JOLLA, Calif., July 14, 2026 (GLOBE NEWSWIRE) — Glucotrack, Inc. (Nasdaq: GCTK) today announced the completion of its strategic business combination with Lōkahi Therapeutics, establishing a publicly listed, capital-efficient platform for the identification, acquisition, and advancement of differentiated healthcare assets. The transaction is structured such that Lōkahi Therapeutics becomes the operating and controlling business of the combined company, leveraging Glucotrack’s public market platform to support long-term growth and access to capital. The combined organization integrates Lōkahi Therapeutics’...

Talen Energy Reports PJM Auction Results for the 2028/2029 Planning Year

Written by Customer Service on July 14, 2026. Posted in Public Companies.

HOUSTON, July 14, 2026 (GLOBE NEWSWIRE) — Talen Energy Corporation (“Talen,” “we,” or “our”) (NASDAQ: TLN), a leading independent power producer, today reported its results from the PJM Base Residual Auction for the 2028/2029 planning year. Talen cleared a total of 10,180 megawatts at a clearing price of $325 per megawatt-day across the PJM Interconnection Regional Transmission Organization, equating to approximately $1,208 million in capacity revenues for the 2028/2029 planning year. The planning year runs from June 1, 2028 through May 31, 2029. About Talen Talen Energy (NASDAQ: TLN) is a leading independent power producer and energy infrastructure company dedicated to powering the future. We own and operate approximately 15.6 gigawatts of power infrastructure in the United States, including 2.2 gigawatts of nuclear power and...

Viking Acquisition Corp. II Announces the Separate Trading of its Class A Ordinary Shares and Warrants Commencing July 20, 2026

Written by Customer Service on July 14, 2026. Posted in Public Companies.

NEW YORK, July 14, 2026 (GLOBE NEWSWIRE) — Viking Acquisition Corp. II (NYSE: VII U) (“Company”) announced today that holders of the Company’s public units may elect to separately trade the Class A ordinary shares and warrants underlying such public units commencing on July 20, 2026. Each unit consists of one Class A ordinary share and one third of one redeemable warrant of the Company. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Those public units not separated will continue to trade under the symbol “VII U.” The Class A ordinary shares and warrants that are separated will trade on the New York Stock Exchange under the ticker symbols “VII” and “VII WS,” respectively. Holders of public units will need to have their brokers contact Continental Stock Transfer & Trust...

ArrowMark Financial Corp. Announces Monthly Cash Distribution of $0.15 per Share for July 2026

Written by Customer Service on July 14, 2026. Posted in Dividend Reports And Estimates.

DENVER, July 14, 2026 (GLOBE NEWSWIRE) — ArrowMark Financial Corp. (Nasdaq: BANX) (“ArrowMark Financial” or the “Company”), an SEC registered closed-end management investment company, today announced that its Board of Directors has declared a monthly cash distribution of $0.15 per share for July 2026. The total distribution of $0.15 per share will be payable on July 31, 2026, to shareholders of record on July 24, 2026. About ArrowMark Financial Corp. ArrowMark Financial Corp. is an SEC registered non-diversified, closed-end fund listed on the NASDAQ Global Select Market under the symbol “BANX.” Its investment objective is to provide shareholders with current income. The Fund pursues its objective by investing primarily in regulatory capital securities of financial institutions. ArrowMark Financial is managed...

Willis Lease Finance Corporation Signs Definitive Agreement to Acquire Commercial Aircraft and Aircraft Engine Portfolio

Written by Customer Service on July 14, 2026. Posted in Mergers And Acquisitions.

Transaction expands WLFC’s lease portfolio by an additional 12 aircraft and 13 engines COCONUT CREEK, Fla., July 14, 2026 (GLOBE NEWSWIRE) — Willis Lease Finance Corporation (NASDAQ: WLFC) (the “Company” or “WLFC”), the leading lessor of commercial aircraft engines and global provider of aviation services, today announced that it has signed a definitive agreement to acquire 12 commercial aircraft and 13 aircraft engines. The acquisition complements WLFC’s broader asset management, technical, and aftermarket capabilities, strengthening the Company’s ability to support customers worldwide throughout the aviation asset lifecycle. “This transaction provides an opportunity to grow our portfolio as well as customer base,” said Austin C. Willis, Chief Executive Officer of WLFC. “It also strengthens our aircraft leasing business, where...

Celcuity Announces FDA Approval of REVTORPYK™ (gedatolisib) for the Treatment of HR+/HER2-, PIK3CA Wild-Type Locally Advanced or Metastatic Breast Cancer

Written by Customer Service on July 14, 2026. Posted in Public Companies.

REVTORPYK (gedatolisib)REVTORPYK (gedatolisib) vial and boxREVTORPYK is the first and only FDA-approved therapy that inhibits all class I PI3K isoforms (α, β, δ, γ) and mTOR complexes mTORC1 and mTORC2In the Phase 3 VIKTORIA-1 trial, REVTORPYK combined with palbociclib and fulvestrant and REVTORPYK combined with fulvestrant reduced the risk of disease progression or death by 76% and 67%, respectively, compared to fulvestrant among patients with PIK3CA wild-type advanced or metastatic breast cancerCelcuity to host webcast and conference call today Tuesday, July 14, 2026, at 5:30 p.m. EDTMINNEAPOLIS, July 14, 2026 (GLOBE NEWSWIRE) — Celcuity Inc. (Nasdaq: CELC), a biotechnology company focused on developing and commercializing targeted therapies for multiple solid tumor indications, today announced that the U.S. Food...

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals